Blueprint Medicines Corp Stock
Your prediction
Blueprint Medicines Corp Stock
So far the community has only identified positive things for Blueprint Medicines Corp stock. The most positive votes were given for criterium "Worthwhile Investment for the next years".
Pros and Cons of Blueprint Medicines Corp in the next few years
Pros
?
W********* I********* f** t** n*** y****
?
S********** s********
?
G***** c******* t* c**********
Cons
?
C******** o* t** e**********
?
M***** P*******
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Blueprint Medicines Corp vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Blueprint Medicines Corp | - | - | - | - | - | - | - |
| Ligand Pharmaceuticals | 2.970% | 1.980% | 3.518% | 126.374% | 24.096% | 209.774% | 122.270% |
| United Therapeutics | -0.420% | -1.202% | -2.594% | 70.504% | 11.608% | 133.431% | 228.897% |
| Ionis Pharmaceuticals Inc. | -0.930% | -1.464% | 0.466% | 109.737% | -4.915% | 63.761% | 127.696% |
News
Webull Q1 Earnings Call Highlights
Key Points
- Interested in Webull Corporation? Here are five stocks we like better.
- Webull posted strong Q1 growth, with revenue up 36% year over year to $159.9 million as trading activity
Old Money, New Tech: Western Union's Crypto Reboot
For years, investors have categorized The Western Union Company (NYSE: WU) as a high-yield value trap, a legacy institution slowly ceding ground to more agile fintech disruptors like Remitly Global
Spirits on the Rocks? The Battle for Jack Daniels
The global premium spirits sector is navigating a significant shift. After a period of high consumer demand driven by COVID-era stay-at-home trends, the market is now normalizing. This return to